Quinn Opportunity Partners LLC Biogen Inc. Transaction History

Quinn Opportunity Partners LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$223.92 - $287.77 $9.3 Million - $11.9 Million	-41,511 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$282.99 - $369.05 $565,980 - $738,100	2,000 Added 5.06%	41,511 $11.7 Million
Q2 2021 Aug 16, 2021	BUY	$259.0 - $414.71 $1.91 Million - $3.06 Million	7,374 Added 22.95%	39,511 $13.7 Million
Q1 2021 May 13, 2021	BUY	$242.95 - $284.63 $5.11 Million - $5.99 Million	21,037 Added 189.52%	32,137 $8.99 Million
Q4 2020 Feb 11, 2021	BUY	$236.26 - $355.63 $2.62 Million - $3.95 Million	11,100 New	11,100 $2.72 Million
Q2 2019 Aug 09, 2019	SELL	$219.29 - $241.72 $438,580 - $483,440	-2,000 Closed	0 $0
Q1 2019 May 07, 2019	BUY	$216.71 - $338.96 $433,420 - $677,920	2,000 New	2,000 $473,000

1,018

128M

1.22M

1.4M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Quinn Opportunity Partners LLC, based on Form 13F filings with the SEC.

Stay updated on Quinn Opportunity Partners LLC with notifications on news.